Comparative Effectiveness and Safety of Atorvastatin Versus Rosuvastatin
Annals of Internal Medicine · 2024-12 · 177 (12) · 1641-1651
DOI: 10.7326/m24-0178 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Annals of Internal Medicine, 2024-12. Verfasst von Shiyu Zhou und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, South…. Hauptthemen laut MEDLINE: Rosuvastatin Calcium, Atorvastatin, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China (S.Z., R.C., J.L., Z.G., L.S.…
ORCID-Profile: Xiaodong Zhang, Xin Xu
Zitieren
APA
Zhou, S., Chen, R., Liu, J., Guo, Z., Su, L., Li, Y., Zhang, X., Luo, F., Gao, Q., Lin, Y., Pang, M., Cao, L., Xu, X., & Nie, S. (2024). Comparative Effectiveness and Safety of Atorvastatin Versus Rosuvastatin. Annals of Internal Medicine, 177(12), 1641-1651. https://doi.org/10.7326/m24-0178
Vancouver
Zhou S, Chen R, Liu J, Guo Z, Su L, Li Y, et al. Comparative Effectiveness and Safety of Atorvastatin Versus Rosuvastatin. Annals of Internal Medicine. 2024;177(12):1641-1651. doi:10.7326/m24-0178
BibTeX
@article{Zhou2024,
author = {Zhou, Shiyu and Chen, Ruixuan and Liu, Jiao and Guo, Zhixin and Su, Licong and Li, Yanqin and Zhang, Xiaodong and Luo, Fan and Gao, Qi and Lin, Yuxin and Pang, Mingzhen and Cao, Lisha and Xu, Xin and Nie, Sheng},
title = {Comparative Effectiveness and Safety of Atorvastatin Versus Rosuvastatin},
journal = {Annals of Internal Medicine},
year = {2024},
volume = {177},
number = {12},
pages = {1641--1651},
doi = {10.7326/m24-0178}
}
EUVIMED